Marie Curie Conference on Paediatric Drug Development

From May 29th to June 1st, 2008 the Istituto Giannina Gaslini Children's Hospital and the Paediatric Rheumatology International Trials Organization (PRINTO) of Genoa, Italy will host “Anticipating Changes in Drug Development for Children: Building on Paediatric Rheumatology”, the first in a Marie Curie Actions-sponsored series of events entitled Translational Research in Paediatric Rheumatology - TRiPR. The meeting, which is meant to further stimulate and mobilise interaction among the three major stakeholders in the drug development process, namely, academia, industry and regulatory authorities, will examine the medicinals research and development process, from pre-clinical and early-phase clinical development, to biomarker validation, study design and management, data analysis, ethical review, regulatory submission and research governance, using the field of rare paediatric rheumatic disorders as a paradigm.

Researchers, clinicians, clinical pharmacologists, pre-clinical and methodological researchers, biostatisticians, and representatives of governmental/non-governmental drug authorities and pharma industries are invited to submit abstracts (deadline: February 15, 2008) on the following topics:
- Networking: pre-clinical and/or clinical results achieved through networking in rare, orphan diseases;
- Methods: biometric and in-silico models for rare, orphan diseases;
- Biomarkers in rheumatic diseases: definition and validation processes.

As many as 60 grants covering registration, hotel and travel expenses will be awarded on a competitive basis to the authors of selected abstracts.

For further information go to : http://www.tripr.sispge.com(opens in new window)